questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential risk that pharmaceutical companies could withdraw compassionate access programmes due to VAT-related financial pressures.
answerText: The Government recognises the important role that compassionate and expanded access programmes can play in enabling patients, particularly those with serious or rare conditions, to access innovative medicines outside routine commissioning arrangements.VAT...
heading: Drugs: VAT